The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Expires: July 31, 2015
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ACLARIS THERAPEUTICS INC COM 00461U105 2,298,267 434,455 SH SOLE 434,455 0 0
BICARA THERAPEUTICS INC COM 055477103 16,891,205 568,919 SH SOLE 568,919 0 0
BIOMEA FUSION INC COM 09077A106 3,011,673 2,048,757 SH SOLE 2,048,757 0 0
BRIDGEBIO ONCOLOGY THERAPEUT COM NEW 107924102 7,757,297 1,018,018 SH SOLE 1,018,018 0 0
BRIDGEBIO PHARMA INC COM 10806X102 341,834,227 4,589,611 SH SOLE 4,589,611 0 0
COMPASS PATHWAYS PLC SPONSORED ADS 20451W101 20,267,554 1,432,336 SH SOLE 1,432,336 0 0
EUPRAXIA PHARMACEUTICALS INC COM 29842P105 2,148,250 325,000 SH SOLE 325,000 0 0
MARKER THERAPEUTICS INC COM NEW 57055L206 478,293 325,370 SH SOLE 325,370 0 0
MONTE ROSA THERAPEUTICS INC COM 61225M102 37,647,069 1,555,664 SH SOLE 1,555,664 0 0
ONKURE THERAPEUTICS INC COM CL A 68277Q105 404,048 88,607 SH SOLE 88,607 0 0
SCHOLAR ROCK HLDG CORP COM 80706P103 4,236,705 77,031 SH SOLE 77,031 0 0
SYNDAX PHARMACEUTICALS INC COM 87164F105 28,785,379 1,316,806 SH SOLE 1,316,806 0 0
UROGEN PHARMA LTD COM M96088105 3,974,400 108,000 SH SOLE 108,000 0 0
VTV THERAPEUTICS INC CL A NEW 918385204 1,882,500 50,000 SH SOLE 50,000 0 0